amran pharmacy limited Company Information
Company Number
06808035
Website
-Registered Address
1 beauchamp court, victors way, barnet, hertfordshire, EN5 5TZ
Industry
Dispensing chemist in specialised stores
Telephone
-
Next Accounts Due
February 2025
Group Structure
View All
Directors
Sujal Patel15 Years
Shareholders
sujal shashikant patel 50%
priti patel 50%
amran pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of AMRAN PHARMACY LIMITED at £85.9k based on a Turnover of £294.8k and 0.29x industry multiple (adjusted for size and gross margin).
amran pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of AMRAN PHARMACY LIMITED at £0 based on an EBITDA of £-269.6k and a 4.29x industry multiple (adjusted for size and gross margin).
amran pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of AMRAN PHARMACY LIMITED at £1.3m based on Net Assets of £509.8k and 2.48x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Amran Pharmacy Limited Overview
Amran Pharmacy Limited is a live company located in barnet, EN5 5TZ with a Companies House number of 06808035. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in February 2009, it's largest shareholder is sujal shashikant patel with a 50% stake. Amran Pharmacy Limited is a established, micro sized company, Pomanda has estimated its turnover at £294.8k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Amran Pharmacy Limited Health Check
Pomanda's financial health check has awarded Amran Pharmacy Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 7 areas for improvement. Company Health Check FAQs
3 Strong
2 Regular
7 Weak
Size
annual sales of £294.8k, make it smaller than the average company (£11.2m)
- Amran Pharmacy Limited
£11.2m - Industry AVG
Growth
3 year (CAGR) sales growth of -13%, show it is growing at a slower rate (5.2%)
- Amran Pharmacy Limited
5.2% - Industry AVG
Production
with a gross margin of 31.4%, this company has a comparable cost of product (31.4%)
- Amran Pharmacy Limited
31.4% - Industry AVG
Profitability
an operating margin of -104.9% make it less profitable than the average company (2.7%)
- Amran Pharmacy Limited
2.7% - Industry AVG
Employees
with 3 employees, this is below the industry average (81)
- Amran Pharmacy Limited
81 - Industry AVG
Pay Structure
on an average salary of £22.4k, the company has an equivalent pay structure (£22.4k)
- Amran Pharmacy Limited
£22.4k - Industry AVG
Efficiency
resulting in sales per employee of £98.3k, this is less efficient (£127.9k)
- Amran Pharmacy Limited
£127.9k - Industry AVG
Debtor Days
it gets paid by customers after 38 days, this is later than average (31 days)
- Amran Pharmacy Limited
31 days - Industry AVG
Creditor Days
its suppliers are paid after 108 days, this is slower than average (68 days)
- Amran Pharmacy Limited
68 days - Industry AVG
Stock Days
it holds stock equivalent to 57 days, this is more than average (31 days)
- Amran Pharmacy Limited
31 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 249 weeks, this is more cash available to meet short term requirements (16 weeks)
249 weeks - Amran Pharmacy Limited
16 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 15.1%, this is a lower level of debt than the average (60.5%)
15.1% - Amran Pharmacy Limited
60.5% - Industry AVG
AMRAN PHARMACY LIMITED financials
Amran Pharmacy Limited's latest turnover from May 2023 is estimated at £294.8 thousand and the company has net assets of £509.8 thousand. According to their latest financial statements, we estimate that Amran Pharmacy Limited has 3 employees and maintains cash reserves of £433.9 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | May 2016 | May 2015 | May 2014 | May 2013 | May 2012 | May 2011 | May 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | ||||||||||||||
Other Income Or Grants | ||||||||||||||
Cost Of Sales | ||||||||||||||
Gross Profit | ||||||||||||||
Admin Expenses | ||||||||||||||
Operating Profit | ||||||||||||||
Interest Payable | ||||||||||||||
Interest Receivable | ||||||||||||||
Pre-Tax Profit | ||||||||||||||
Tax | ||||||||||||||
Profit After Tax | ||||||||||||||
Dividends Paid | ||||||||||||||
Retained Profit | ||||||||||||||
Employee Costs | ||||||||||||||
Number Of Employees | 7 | 5 | 7 | 7 | 7 | 6 | ||||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | May 2016 | May 2015 | May 2014 | May 2013 | May 2012 | May 2011 | May 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 14,241 | 6,849 | 3,702 | 4,936 | 6,580 | 3,538 | 4,717 | 6,289 | 8,385 | 11,180 | 13,842 | 13,756 | 18,341 | 24,455 |
Intangible Assets | 0 | 152,500 | 190,625 | 228,750 | 266,875 | 305,000 | 343,125 | 495,625 | 533,750 | 571,875 | 610,000 | 648,125 | 686,250 | 724,375 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 14,241 | 159,349 | 194,327 | 233,686 | 273,455 | 308,538 | 347,842 | 501,914 | 542,135 | 583,055 | 623,842 | 661,881 | 704,591 | 748,830 |
Stock & work in progress | 32,111 | 26,121 | 22,101 | 34,650 | 39,975 | 26,862 | 31,576 | 33,869 | 32,122 | 33,748 | 33,091 | 36,621 | 40,206 | 49,525 |
Trade Debtors | 31,228 | 1,712 | 34,675 | 36,508 | 0 | 72,501 | 110,465 | 80,954 | 104,436 | 100,586 | 93,152 | 182,599 | 200,672 | 180,450 |
Group Debtors | 50,000 | 50,000 | 250,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 38,803 | 20,417 | 16,925 | 19,134 | 11,205 | 43,612 | 72,660 | 18,458 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 433,860 | 608,411 | 374,440 | 447,396 | 314,171 | 255,756 | 80,996 | 46,700 | 23,322 | 225,323 | 110,874 | 58,172 | 25,491 | 63,850 |
misc current assets | 0 | 101,355 | 101,355 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 586,002 | 808,016 | 799,496 | 639,043 | 466,706 | 398,731 | 295,697 | 179,981 | 159,880 | 359,657 | 237,117 | 277,392 | 266,369 | 293,825 |
total assets | 600,243 | 967,365 | 993,823 | 872,729 | 740,161 | 707,269 | 643,539 | 681,895 | 702,015 | 942,712 | 860,959 | 939,273 | 970,960 | 1,042,655 |
Bank overdraft | 0 | 0 | 50,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 60,232 | 83,164 | 42,840 | 54,175 | 85,625 | 81,347 | 102,062 | 94,049 | 134,685 | 384,837 | 442,696 | 597,688 | 794,024 | 967,340 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 30,166 | 88,585 | 138,399 | 124,124 | 38,542 | 32,922 | 51,632 | 51,859 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 90,398 | 171,749 | 231,239 | 178,299 | 124,167 | 114,269 | 153,694 | 145,908 | 134,685 | 384,837 | 442,696 | 597,688 | 794,024 | 967,340 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total liabilities | 90,398 | 171,749 | 231,239 | 178,299 | 124,167 | 114,269 | 153,694 | 145,908 | 134,685 | 384,837 | 442,696 | 597,688 | 794,024 | 967,340 |
net assets | 509,845 | 795,616 | 762,584 | 694,430 | 615,994 | 593,000 | 489,845 | 535,987 | 567,330 | 557,875 | 418,263 | 341,585 | 176,936 | 75,315 |
total shareholders funds | 509,845 | 795,616 | 762,584 | 694,430 | 615,994 | 593,000 | 489,845 | 535,987 | 567,330 | 557,875 | 418,263 | 341,585 | 176,936 | 75,315 |
May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | May 2016 | May 2015 | May 2014 | May 2013 | May 2012 | May 2011 | May 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||||
Operating Profit | ||||||||||||||
Depreciation | 1,508 | 1,944 | 1,234 | 1,644 | 2,198 | 1,179 | 1,572 | 2,096 | 2,795 | 3,727 | 4,614 | 4,585 | 6,114 | 8,152 |
Amortisation | 38,125 | 38,125 | 38,125 | 38,125 | 38,125 | 38,125 | 38,125 | 38,125 | 38,125 | 38,125 | 38,125 | 38,125 | 38,125 | 38,125 |
Tax | ||||||||||||||
Stock | 5,990 | 4,020 | -12,549 | -5,325 | 13,113 | -4,714 | -2,293 | 1,747 | -1,626 | 657 | -3,530 | -3,585 | -9,319 | 49,525 |
Debtors | 47,902 | -229,471 | 245,958 | 44,437 | -104,908 | -67,012 | 83,713 | -5,024 | 3,850 | 7,434 | -89,447 | -18,073 | 20,222 | 180,450 |
Creditors | -22,932 | 40,324 | -11,335 | -31,450 | 4,278 | -20,715 | 8,013 | -40,636 | -250,152 | -57,859 | -154,992 | -196,336 | -173,316 | 967,340 |
Accruals and Deferred Income | -58,419 | -49,814 | 14,275 | 85,582 | 5,620 | -18,710 | -227 | 51,859 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | ||||||||||||||
Investing Activities | ||||||||||||||
capital expenditure | ||||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | ||||||||||||||
Financing Activities | ||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | ||||||||||||||
interest | ||||||||||||||
cash flow from financing | ||||||||||||||
cash and cash equivalents | ||||||||||||||
cash | -174,551 | 233,971 | -72,956 | 133,225 | 58,415 | 174,760 | 34,296 | 23,378 | -202,001 | 114,449 | 52,702 | 32,681 | -38,359 | 63,850 |
overdraft | 0 | -50,000 | 50,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | -174,551 | 283,971 | -122,956 | 133,225 | 58,415 | 174,760 | 34,296 | 23,378 | -202,001 | 114,449 | 52,702 | 32,681 | -38,359 | 63,850 |
amran pharmacy limited Credit Report and Business Information
Amran Pharmacy Limited Competitor Analysis
Perform a competitor analysis for amran pharmacy limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other micro companies, companies in EN5 area or any other competitors across 12 key performance metrics.
amran pharmacy limited Ownership
AMRAN PHARMACY LIMITED group structure
Amran Pharmacy Limited has no subsidiary companies.
Ultimate parent company
AMRAN PHARMACY LIMITED
06808035
amran pharmacy limited directors
Amran Pharmacy Limited currently has 1 director, Mr Sujal Patel serving since Mar 2009.
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Sujal Patel | United Kingdom | 49 years | Mar 2009 | - | Director |
P&L
May 2023turnover
294.8k
-22%
operating profit
-309.2k
0%
gross margin
31.4%
-4.77%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
May 2023net assets
509.8k
-0.36%
total assets
600.2k
-0.38%
cash
433.9k
-0.29%
net assets
Total assets minus all liabilities
amran pharmacy limited company details
company number
06808035
Type
Private limited with Share Capital
industry
47730 - Dispensing chemist in specialised stores
incorporation date
February 2009
age
15
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
May 2023
previous names
amran pharma limited (May 2009)
tinseltown (palmers green) ltd (April 2009)
accountant
BBK PARTNERSHIP
auditor
-
address
1 beauchamp court, victors way, barnet, hertfordshire, EN5 5TZ
Bank
-
Legal Advisor
-
amran pharmacy limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to amran pharmacy limited.
amran pharmacy limited Companies House Filings - See Documents
date | description | view/download |
---|